S-1/A: ClearSign Files S-1/A for Warrant Shares Amid Nasdaq Delisting Concerns

Sentiment:

Registration Statement Amendment


ClearSign Technologies Corporation files an S-1/A to register 5.27 million common shares underlying outstanding warrants, while addressing Nasdaq listing compliance issues and announcing a new ATM program.

Capital raiseThe company has the potential to receive up to $5.5 million in gross proceeds from the exercise of 5,267,222 outstanding redeemable warrants at an exercise price of $1.05 per share.A new At The Market Offering Agreement was entered into with H.C. Wainwright & Co., LLC on July 17, 2025, allowing the company to offer and sell up to $10,390,000 of common stock.The company previously raised approximately $6,122,650 from the sale of 1,594,285 shares under a terminated At-the-Market Sales Agreement with Virtu Americas LLC.Historically, the company's operations have been primarily financed through the issuance of equity securities.
Worse than expectedThe common stock's closing bid price of $0.5353 on August 19, 2025, is significantly below Nasdaq's $1 minimum bid price requirement, indicating a high risk of delisting.The company received two separate Nasdaq non-compliance notices: one for the minimum bid price and another for failing to meet board independence and audit committee composition requirements.The exercise price of the outstanding warrants ($1.05) is substantially higher than the current market price, making it unlikely that warrant holders will exercise, thereby limiting the potential capital inflow from this source.The company explicitly states a history of operating losses and negative cash flows, with an expectation for these to continue in the near future.

Summary

  • ClearSign Technologies Corporation has filed an S-1/A to register 5,267,222 shares of common stock that are issuable upon the exercise of outstanding redeemable warrants.
  • The warrants, issued in April 2024, have an exercise price of $1.05 per share and expire five years from their issuance date.
  • The company could receive up to $5.5 million in gross proceeds if all warrants are exercised, which would be used for working capital, research and development, marketing and sales, and general corporate purposes.
  • ClearSign is currently non-compliant with Nasdaq's $1 minimum bid price requirement, with the closing bid price at $0.5353 as of August 19, 2025, and a deadline to regain compliance by September 29, 2025.
  • The company also received a Nasdaq notice for non-compliance with board independence and audit committee composition requirements due to two director resignations on August 4, 2026, with a cure period extending to August 4, 2026, or February 2, 2026.
  • ClearSign terminated its previous At-the-Market (ATM) sales agreement with Virtu Americas LLC, which had generated approximately $6.12 million from the sale of 1,594,285 shares.
  • A new ATM agreement was entered into with H.C. Wainwright & Co., LLC on July 17, 2025, allowing the company to sell up to $10.39 million in common stock.
  • As of June 30, 2025, the historical net tangible book value was approximately $9.6 million, or $0.18 per share, which would increase to approximately $15.1 million, or $0.26 per share, pro forma if all warrants are exercised.

Sentiment

Score: 3

Explanation: The company faces immediate and severe risks of delisting from Nasdaq due to both minimum bid price and corporate governance non-compliance. While it has promising technology and access to capital through a new ATM program, the current stock price makes the warrant exercise unlikely, and the overall financial health is precarious with a history of losses and expected continued negative cash flows. This indicates significant downside risk for investors.

Positives

  • The registration of shares underlying warrants provides a potential source of capital, up to $5.5 million, for working capital, R&D, marketing, and general corporate purposes.
  • The new At-the-Market (ATM) agreement with H.C. Wainwright & Co., LLC provides access to up to $10.39 million in additional capital, enhancing financial flexibility.
  • The company's ClearSign Core technology is designed for decarbonization and improving industrial combustion systems, addressing a growing market need driven by stringent environmental regulations.
  • ClearSign Core technology has been successfully deployed in commercial projects and is believed to be more effective and cost-efficient than current industry-standard air pollution control technologies.
  • The ClearSign Eye sensing products offer future diversification and growth opportunities, including a collaboration with Narion Corporation for transportation markets.

Negatives

  • The common stock's closing bid price of $0.5353 on August 19, 2025, is significantly below the warrant exercise price of $1.05, making it unlikely that warrant holders will exercise their warrants in the near term, thus limiting immediate capital inflow from this source.
  • The company is at risk of delisting from Nasdaq due to non-compliance with the $1 minimum bid price requirement, with a compliance deadline of September 29, 2025.
  • ClearSign is also non-compliant with Nasdaq's board independence and audit committee composition requirements, posing another delisting risk.
  • The company has a history of operating losses and negative cash flows, with an expectation for these trends to continue in the near future.
  • Revenue has been highly concentrated among a small number of customers, posing a significant risk if a key revenue source is lost.
  • Existing shareholders face potential significant dilution if warrants are exercised and future equity offerings occur.
  • The company has limited authorized shares available for future financing without an increase in authorized capital, which could restrict its ability to secure additional funding.

Risks

  • Inability to regain compliance with Nasdaq's $1 minimum bid price requirement, potentially leading to delisting of common stock.
  • Failure to regain compliance with Nasdaq's board independence and audit committee composition requirements, which could also result in delisting.
  • Potential for significant decline in common stock price if warrant holders exercise their warrants in full and sell a substantial number of shares in the public market.
  • Limited availability of authorized common stock for future capital needs, which may necessitate less favorable financing structures or force the company to downsize operations.
  • Broad discretion in the application of proceeds received from warrant exercises, which may not necessarily improve profitability or increase the common stock price.
  • Future dilution for existing stockholders from the issuance of shares underlying warrants, future equity offerings, and other issuances of common stock or other securities.
  • Volatility in the price of common stock due to factors such as progress in technology development, changes in investor perception, customer relationships, and general market conditions.
  • Continued operating losses and negative cash flows in the near future, given the company's limited cash and history of losses.
  • Challenges in successfully developing and implementing technologies and achieving sustained profitability.
  • Changes in government regulations that could reduce or eliminate the demand for the company's technology.
  • Emerging competition and rapidly advancing technology in the industry that may outpace the company's offerings.
  • Impact of global supply-chain constraints and the threat or implementation of tariffs on commercialization efforts and business operations.
  • High concentration of revenue among a small number of customers, making the company vulnerable to the loss of key revenue sources.
  • Potential impact of cybersecurity incidents or other technology disruptions on business operations.
  • Inability to adequately protect intellectual property, which could undermine competitive advantage.
  • Challenges in obtaining adequate financing in the future to support operations and growth.
  • Difficulties in retaining and hiring personnel with the necessary experience and talent to develop products and business.

Future Outlook

The company expects to continue experiencing operating losses and negative cash flows in the near future. It aims to provide cost-effective pollution control solutions and diversify with sensing technologies, but commercialization for transportation markets will take time and is not assured. The company intends to monitor its stock price and take actions to regain Nasdaq compliance, including appointing new independent directors.

Management Comments

  • "We believe that our patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets."
  • "We believe that combustion equipment utilizing ClearSign CoreTM technology is more effective and cost-efficient than current industry-standard air pollution control technologies and can reduce nitrogen oxide (NOx) emissions down to the levels required by new stringent emission regulations."
  • "We believe that our ClearSign CoreTM technology can provide value to our customers not only by helping them meet current and possible future legislative mandates to reduce pollutant emissions, but also by improving operating efficiency and increasing overall return on investment."
  • "We believe that these potential costs savings could produce a significantly attractive pay-back period for an investment in ClearSign CoreTM technology-based burners."
  • "We believe that the opportunities for application of our sensing technology in the transportation market are global and of great value, but it will also take longer to commercialize products targeted for this market for the reasons stated above."
  • "Overall, our sensing technologies could provide future diversification as well as the opportunity for continued business expansion and growth beyond the maturation of our combustion-related businesses."
  • "We intend to monitor the closing bid price of our common stock and consider its available options in the event that the closing bid price of our common stock remains below $1 per share."
  • "We intend to regain compliance with the Nasdaq Composition Requirements by appointing a new director to the board of directors and Audit Committee who meets the independence requirements under Nasdaq rules and Rule 10A-3(b)(1) under the Exchange Act."

Industry Context

ClearSign Technologies operates within the significant combustion and emissions control systems markets, which are driven by increasing global environmental regulations, particularly concerning nitrogen oxide (NOx) emissions. The company's ClearSign Core technology aims to provide a more cost-effective and efficient alternative to existing industry standards like Selective Catalytic Reduction (SCR) devices and traditional low NOx burners. Its primary target markets are within the energy sector, including petroleum refining process heaters, energy infrastructure process heaters, boilers, and enclosed flares. The development of its ClearSign Eye sensing technology represents a strategic move towards diversification beyond the core combustion industry, with potential applications in the transportation sector.

Comparison to Industry Standards

  • ClearSign Core technology is positioned as more effective and cost-efficient than current industry-standard air pollution control technologies, including selective catalytic reduction devices (SCRs), lowand ultra-low NOx burners, and external flue gas recirculation systems.
  • Burners utilizing ClearSign Core technology are reported to provide increased heat transfer efficiency, potentially leading to low to mid-single digit percentage cost savings compared to other emission reducing technologies.
  • Heaters employing ClearSign Core technology are expected to operate at a lower cost, have increased productivity, and require less maintenance and downtime due to smaller flame volumes compared to traditional low NOx burners that produce enlarged flames.
  • The technology is anticipated to virtually eliminate flame impingement and enable burners to function better in tightly spaced heaters, unlike traditional low NOx burners.
  • Installation of ClearSign's technology has the potential to decrease process downtime compared to retrofits utilizing legacy SCRs or flue gas recirculation systems.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorCatharine M. de LacyN/AAugust 4, 2026Resignation, contributing to Nasdaq board independence non-compliance.
DirectorJudith S. SchreckerN/AAugust 4, 2026Resignation, contributing to Nasdaq audit committee composition non-compliance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Composition Non-ComplianceThe board of directors does not have a majority of independent directors following recent resignations.August 8, 2025 (notice date)This non-compliance poses a risk of Nasdaq delisting if not cured by the specified deadline (August 4, 2026, or February 2, 2026).
Audit Committee Composition Non-ComplianceThe Audit Committee consists of only two independent directors, falling short of the minimum three required by Nasdaq rules.August 8, 2025 (notice date)This non-compliance poses a risk of Nasdaq delisting if not cured by the specified deadline (August 4, 2026, or February 2, 2026).

Stakeholder Impact

  • Shareholders face significant potential dilution from the exercise of warrants and future equity offerings, coupled with a high risk of Nasdaq delisting and stock price volatility.
  • Employees' continued employment and the company's operational stability are dependent on successful capital raises and regaining Nasdaq compliance.
  • Customers may benefit from the continued development and deployment of the company's emissions reduction and sensing technologies, assuming the company maintains operations.
  • Creditors face increased risk due to the company's history of operating losses, expected negative cash flows, and the ongoing Nasdaq delisting concerns, despite potential capital infusions.

Next Steps

  • Monitor the closing bid price of common stock and consider options to regain Nasdaq minimum bid price compliance by September 29, 2025.
  • Appoint a new director to the board of directors and Audit Committee who meets Nasdaq independence requirements to regain compliance by August 4, 2026, or February 2, 2026, whichever is earlier.
  • Continue efforts to commercialize ClearSign Eye sensing technology, which requires further development, refinement of specific products, obtaining certifications, and establishing efficient manufacturing and market channels.
  • Utilize any net proceeds from warrant exercises and the new ATM program for working capital, research and development, marketing and sales, and general corporate purposes.

Key Dates

DateDescription
January 23, 2008Company incorporated in the State of Washington.
May 6, 2013ClearSign Combustion Corporation 2013 Consultant Stock Plan referenced.
June 20, 2016Lease Agreement entered into.
July 12, 2018Stock Purchase Agreement with clirSPV LLC dated.
January 28, 2019Employment Agreement with Colin James Deller dated.
July 29, 2019First Amendment to Lease entered into.
January 14, 2020Second Amendment to Lease entered into.
December 23, 2020At-the-Market Sales Agreement with Virtu Americas LLC dated.
May 7, 2021ClearSign Technologies Corporation 2021 Equity Incentive Plan referenced.
October 18, 2021Offer Letter with Brent Hinds dated.
March 31, 2022Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed.
August 12, 2022Prior shelf registration statement on Form S-3 declared effective.
August 15, 2022Amendment to Employment Agreement between the Company and Colin James Deller.
June 14, 2023Company changed domicile from Washington to Delaware.
August 8, 2023Amendment to Offer Letter between the Company and Brent Hinds.
August 14, 2023Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 filed.
April 19, 2024Form 8-K filed regarding warrant forms.
April 23, 2024Underwritten public offering completed, and redeemable warrants issued. Warrants became exercisable immediately.
May 15, 2024Underwriters exercised over-allotment option in full.
June 24, 2024clirSPV LLC exercised its participation right.
August 1, 2024G. Todd Silvas Offer Letter effective.
August 6, 2024Form 8-K filed regarding G. Todd Silvas Offer Letter.
October 16, 2024Underwriter Warrants and Placement Agent Warrants became exercisable.
December 31, 2024Fiscal year end for consolidated financial statements.
March 31, 2025Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed.
April 1, 2025Received Nasdaq notice for minimum bid price non-compliance.
May 15, 2025Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 filed.
May 22, 2025Cooperation Agreements with Richard D. Clarkson and Anthony DiGiandomenico, and Offer Letters for Louis J. Basenese and Anthony DiGiandomenico effective.
May 23, 2025Form 8-K filed.
May 27, 2025Form 8-K filed.
May 28, 2025Annual Report on Form 10-K/A for the fiscal year ended December 31, 2024 filed.
June 30, 2025Date for historical net tangible book value calculation.
July 11, 2025Form 8-K filed.
July 12, 2025At-the-Market Sales Agreement with Virtu Americas LLC terminated.
July 17, 2025Entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC.
July 18, 2025Form 8-K filed.
July 28, 2025Registration Statement for new ATM program declared effective. Form 8-K filed.
August 8, 2025Received Nasdaq notice for board independence and audit committee composition non-compliance. Form 8-K filed.
August 12, 2025Prior Registration Statement on Form S-3 expired.
August 14, 2025Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 filed.
August 15, 2025Form 8-K filed.
August 19, 2025Last reported sale price of common stock on Nasdaq was $0.5353.
August 20, 2025Filing date of Amendment No. 1 to Form S-1 Registration Statement.
September 29, 2025Deadline to regain Nasdaq minimum bid price compliance.
February 2, 2026Alternative cure period end for Nasdaq board independence and audit committee composition compliance.
August 4, 2026Resignation date of Catharine M. de Lacy and Judith S. Schrecker from the board of directors. Also, the latest cure period end for Nasdaq board independence and audit committee composition compliance.

Recommendation

sell

The company faces immediate and severe risks of delisting from Nasdaq due to both minimum bid price and corporate governance non-compliance. The current stock price is significantly below the warrant exercise price, making the potential capital inflow from warrant exercises unlikely in the near term. Despite a new ATM program, the company has a history of operating losses and negative cash flows, with expectations for this to continue. These factors indicate significant downside risk and a highly speculative investment, warranting a sell recommendation for existing holdings and avoidance for new investments.

Keywords

ClearSign Technologies, CLIR, SEC Filing, S-1/A, Warrants, Nasdaq, Delisting Risk, Capital Raise, Emissions Control, Combustion Technology, Decarbonization, Air Pollution, Industrial Burners, Process Heaters, Boilers, ClearSign Core, ClearSign Eye, Equity Offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.